• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力患者胸腺和淋巴结中产生乙酰胆碱受体抗体的细胞

Acetylcholine receptor antibody-producing cells in thymus and lymph nodes in myasthenia gravis.

作者信息

Fujii Y, Monden Y, Hashimoto J, Nakahara K, Kawashima Y

出版信息

Clin Immunol Immunopathol. 1985 Jan;34(1):141-6. doi: 10.1016/0090-1229(85)90018-2.

DOI:10.1016/0090-1229(85)90018-2
PMID:4038384
Abstract

Eleven patients with myasthenia gravis (5 with thymoma) were studied and spontaneous production of antibody to acetylcholine receptor (AChR) in vitro was found by thymus cells in 10 (and in all 5 with thymoma) and by lymph node cells in 8 (and in 3 with thymoma). The rate of AChR antibody production by thymus cells was greater than that by lymph node cells (10.7 +/- 11.6 and 1.4 +/- 1.5 fmol/10(6) cells/week, respectively, mean +/- SD, P less than 0.05 by paired t test), although the B-cell population was always smaller in the thymus than in the lymph nodes (9.5 +/- 9.4 and 31 +/- 12.7%, P less than 0.001), suggesting the principal role of the thymus in AChR antibody production. It is suggested that lymph nodes can be one of the main sites of AChR antibody production in myasthenia gravis but the antibody-producing cells may originate in the thymus.

摘要

对11例重症肌无力患者(5例伴有胸腺瘤)进行了研究,发现胸腺细胞在体外可使10例患者(所有5例伴有胸腺瘤的患者均如此)自发产生抗乙酰胆碱受体(AChR)抗体,淋巴结细胞可使8例患者(3例伴有胸腺瘤的患者)产生该抗体。胸腺细胞产生AChR抗体的速率高于淋巴结细胞(分别为10.7±11.6和1.4±1.5 fmol/10⁶细胞/周,均值±标准差,配对t检验P<0.05),尽管胸腺中的B细胞群体总是比淋巴结中的小(分别为9.5±9.4%和31±12.7%,P<0.001),这表明胸腺在AChR抗体产生中起主要作用。提示淋巴结可能是重症肌无力中AChR抗体产生的主要部位之一,但产生抗体的细胞可能起源于胸腺。

相似文献

1
Acetylcholine receptor antibody-producing cells in thymus and lymph nodes in myasthenia gravis.重症肌无力患者胸腺和淋巴结中产生乙酰胆碱受体抗体的细胞
Clin Immunol Immunopathol. 1985 Jan;34(1):141-6. doi: 10.1016/0090-1229(85)90018-2.
2
Antibody to acetylcholine receptor in myasthenia gravis: production by lymphocytes from thymus or thymoma.重症肌无力中抗乙酰胆碱受体抗体:由胸腺或胸腺瘤中的淋巴细胞产生。
Neurology. 1984 Sep;34(9):1182-6. doi: 10.1212/wnl.34.9.1182.
3
Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.两例无乙酰胆碱受体抗体的胸腺瘤相关性重症肌无力病例。
Neuromuscul Disord. 2008 Aug;18(8):678-80. doi: 10.1016/j.nmd.2008.06.368. Epub 2008 Jul 25.
4
Thymus, thymoma and myasthenia gravis.胸腺、胸腺瘤和重症肌无力。
Surg Today. 2013 May;43(5):461-6. doi: 10.1007/s00595-012-0318-2. Epub 2012 Sep 5.
5
Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology.胸腺淋巴细胞合成乙酰胆碱受体抗体:与胸腺组织学的相关性。
Neurology. 1981 Aug;31(8):935-43. doi: 10.1212/wnl.31.8.935.
6
Thymus, thymoma, and specific T cells in myasthenia gravis.重症肌无力中的胸腺、胸腺瘤及特异性T细胞。
Ann N Y Acad Sci. 1998 May 13;841:371-87. doi: 10.1111/j.1749-6632.1998.tb10950.x.
7
Anti-acetylcholine receptor antibody synthesis by cultured lymphocytes in myasthenia gravis: thymic and peripheral blood cell interactions.重症肌无力中培养淋巴细胞合成抗乙酰胆碱受体抗体:胸腺与外周血细胞的相互作用
Ann N Y Acad Sci. 1981;377:393-402. doi: 10.1111/j.1749-6632.1981.tb33747.x.
8
Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.日本胸腺瘤组织学与肌特异性受体酪氨酸激酶抗体阳性重症肌无力伴发自身免疫性疾病的相关性。
Eur J Neurol. 2013 Sep;20(9):1272-6. doi: 10.1111/ene.12169. Epub 2013 May 17.
9
Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.重症肌无力患者胸腺瘤细胞自发产生抗干扰素-α和抗白细胞介素-12自身抗体,提示肿瘤中存在自身免疫现象。
Int Immunol. 2003 Aug;15(8):903-13. doi: 10.1093/intimm/dxg088.
10
Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells.重症肌无力患者胸腺瘤上皮细胞向潜在致病性T细胞的抗原呈递。
J Neuroimmunol. 1995 Jan;56(1):65-76. doi: 10.1016/0165-5728(94)00134-a.

引用本文的文献

1
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies.重症肌无力:分子治疗时代不断变化的治疗前景。
Nat Rev Neurol. 2024 Feb;20(2):84-98. doi: 10.1038/s41582-023-00916-w. Epub 2024 Jan 8.
2
Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma.胸腺瘤中骨髓胸腺上皮细胞导致重症肌无力特异性异常神经肌肉基因表达。
Nat Commun. 2022 Jul 22;13(1):4230. doi: 10.1038/s41467-022-31951-8.
3
Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature.
重症肌无力的单细胞分析确定了一种致病性 T 细胞特征。
Acta Neuropathol. 2021 Jun;141(6):901-915. doi: 10.1007/s00401-021-02299-y. Epub 2021 Mar 28.
4
Thymus and autoimmunity.胸腺与自身免疫。
Semin Immunopathol. 2021 Feb;43(1):45-64. doi: 10.1007/s00281-021-00842-3. Epub 2021 Feb 3.
5
Thymus-derived B cell clones persist in the circulation after thymectomy in myasthenia gravis.胸腺瘤切除术后重症肌无力患者循环中存在胸腺来源的 B 细胞克隆。
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30649-30660. doi: 10.1073/pnas.2007206117. Epub 2020 Nov 16.
6
Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology.重症肌无力疾病亚型中的自身免疫病理学由免疫病理学的不同机制控制。
Front Immunol. 2020 May 27;11:776. doi: 10.3389/fimmu.2020.00776. eCollection 2020.
7
Amyloid deposition in thymic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in a patient with myasthenia gravis: A case report.重症肌无力患者黏膜相关淋巴组织结外边缘区淋巴瘤的胸腺内淀粉样沉积:病例报告。
Thorac Cancer. 2020 Mar;11(3):781-784. doi: 10.1111/1759-7714.13294. Epub 2020 Jan 15.
8
Therapies Directed Against B-Cells and Downstream Effectors in Generalized Autoimmune Myasthenia Gravis: Current Status.针对广义自身免疫性重症肌无力中 B 细胞及下游效应物的治疗方法:现状。
Drugs. 2019 Mar;79(4):353-364. doi: 10.1007/s40265-019-1065-0.
9
B cells in the pathophysiology of myasthenia gravis.B 细胞在重症肌无力的病理生理学中的作用。
Muscle Nerve. 2018 Feb;57(2):172-184. doi: 10.1002/mus.25973. Epub 2017 Sep 30.
10
Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.重症肌无力中 Toll 样受体激活的研究进展:在新型实验模型开发中的应用。
Clin Rev Allergy Immunol. 2017 Feb;52(1):133-147. doi: 10.1007/s12016-016-8549-4.